Condition: Monoclonal Gammopathy of Undetermined Significance · Myeloma Multiple · Sponsor: University Hospital, Rouen
No effective specific treatment is currently available for the management of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS). A better understanding of the pathophysiological mechanisms would make it possible to propose treatments specifically targeting the deregulated pathways.
This description comes directly from the study's public registry record.
Abdellah AB TEBANI, Pr · 02 32 88 81 24 · Abdellah.Tebani@chu-rouen.fr
Soumeya BEKRI, Pr · 02 32 88 81 24 · soumeya.bekri@chu-rouen.fr
Always discuss trial participation with your own doctor first.
| Centre Henri Becquerel | Rouen, France | Not Yet Recruiting |
| University Rouen Hospital | Rouen, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06559033